Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-24-044764
Filing Date
2024-11-12
Accepted
2024-11-12 16:15:42
Documents
95
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 951945
2 ex10-3.htm EX-10.3 97132
3 ex31-1.htm EX-31.1 19245
4 ex31-2.htm EX-31.2 19209
5 ex32-1.htm EX-32.1 7080
6 ex32-2.htm EX-32.2 7406
  Complete submission text file 0001493152-24-044764.txt   6031897

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE xtnt-20240930.xsd EX-101.SCH 49170
8 XBRL CALCULATION FILE xtnt-20240930_cal.xml EX-101.CAL 84056
9 XBRL DEFINITION FILE xtnt-20240930_def.xml EX-101.DEF 197315
10 XBRL LABEL FILE xtnt-20240930_lab.xml EX-101.LAB 411650
11 XBRL PRESENTATION FILE xtnt-20240930_pre.xml EX-101.PRE 356883
97 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 805872
Mailing Address 664 CRUISER LANE BELGRADE MT 59714
Business Address 664 CRUISER LANE BELGRADE MT 59714 406-388-0480
Xtant Medical Holdings, Inc. (Filer) CIK: 0001453593 (see all company filings)

EIN.: 205313323 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34951 | Film No.: 241448398
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)